Showing results 1 to 4 of 4
Title | Author(s) | Issue Date | Views | |
---|---|---|---|---|
2021 | 13 | |||
Impact of epidermal growth factor receptor inhibitor in non-small cell lung cancer on progression-free an overall survival: a meta-analysis Journal:Journal of the National Cancer Institute | 2013 | 82 | ||
Phase 3 study of first-line crizotinib vs pemetrexed−cisplatin/carboplatin in East Asian patients with ALK+ advanced non-squamous non-small cell lung cancer (NSCLC) Proceeding/Conference:Journal of Clinical Oncology | 2016 | 291 | ||
2018 | 56 |